nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxazepam—UGT2B7—Epirubicin—ovarian cancer	0.233	0.311	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Paclitaxel—ovarian cancer	0.0807	0.108	CbGbCtD
Oxazepam—CYP3A7—Paclitaxel—ovarian cancer	0.0807	0.108	CbGbCtD
Oxazepam—CYP3A5—Paclitaxel—ovarian cancer	0.0605	0.0807	CbGbCtD
Oxazepam—CYP3A7-CYP3A51P—Docetaxel—ovarian cancer	0.0583	0.0778	CbGbCtD
Oxazepam—CYP3A7—Docetaxel—ovarian cancer	0.0583	0.0778	CbGbCtD
Oxazepam—CYP3A4—Topotecan—ovarian cancer	0.0477	0.0636	CbGbCtD
Oxazepam—CYP3A5—Docetaxel—ovarian cancer	0.0437	0.0583	CbGbCtD
Oxazepam—CYP3A4—Vinorelbine—ovarian cancer	0.0336	0.0448	CbGbCtD
Oxazepam—CYP3A4—Paclitaxel—ovarian cancer	0.0236	0.0315	CbGbCtD
Oxazepam—CYP3A4—Docetaxel—ovarian cancer	0.0171	0.0228	CbGbCtD
Oxazepam—CYP3A4—Doxorubicin—ovarian cancer	0.0127	0.017	CbGbCtD
Oxazepam—Ataxia—Altretamine—ovarian cancer	0.00726	0.0533	CcSEcCtD
Oxazepam—Vertigo—Altretamine—ovarian cancer	0.00418	0.0307	CcSEcCtD
Oxazepam—Leukopenia—Altretamine—ovarian cancer	0.00416	0.0306	CcSEcCtD
Oxazepam—Menstruation irregular—Docetaxel—ovarian cancer	0.00296	0.0218	CcSEcCtD
Oxazepam—CYP3A43—testis—ovarian cancer	0.00294	0.0684	CbGeAlD
Oxazepam—UGT2B15—female reproductive system—ovarian cancer	0.0026	0.0604	CbGeAlD
Oxazepam—Ataxia—Chlorambucil—ovarian cancer	0.00258	0.019	CcSEcCtD
Oxazepam—Dizziness—Altretamine—ovarian cancer	0.00251	0.0184	CcSEcCtD
Oxazepam—Lethargy—Topotecan—ovarian cancer	0.00249	0.0183	CcSEcCtD
Oxazepam—Blood disorder—Paclitaxel—ovarian cancer	0.00232	0.017	CcSEcCtD
Oxazepam—Nausea—Altretamine—ovarian cancer	0.00225	0.0166	CcSEcCtD
Oxazepam—Lethargy—Vinorelbine—ovarian cancer	0.00213	0.0157	CcSEcCtD
Oxazepam—Body temperature increased—Carboplatin—ovarian cancer	0.00207	0.0152	CcSEcCtD
Oxazepam—Jaundice—Chlorambucil—ovarian cancer	0.00206	0.0151	CcSEcCtD
Oxazepam—Hallucination—Chlorambucil—ovarian cancer	0.00189	0.0139	CcSEcCtD
Oxazepam—Jaundice—Melphalan—ovarian cancer	0.0018	0.0132	CcSEcCtD
Oxazepam—GABRP—uterine cervix—ovarian cancer	0.00174	0.0405	CbGeAlD
Oxazepam—GABRE—myometrium—ovarian cancer	0.00171	0.0397	CbGeAlD
Oxazepam—GABRP—decidua—ovarian cancer	0.00166	0.0386	CbGeAlD
Oxazepam—UGT2B7—female reproductive system—ovarian cancer	0.00159	0.0369	CbGeAlD
Oxazepam—GABRP—endometrium—ovarian cancer	0.00157	0.0366	CbGeAlD
Oxazepam—Tremor—Chlorambucil—ovarian cancer	0.00155	0.0114	CcSEcCtD
Oxazepam—GABRG3—testis—ovarian cancer	0.00152	0.0354	CbGeAlD
Oxazepam—Agitation—Chlorambucil—ovarian cancer	0.00152	0.0112	CcSEcCtD
Oxazepam—Agranulocytosis—Vinorelbine—ovarian cancer	0.0015	0.011	CcSEcCtD
Oxazepam—Leukopenia—Chlorambucil—ovarian cancer	0.00148	0.0109	CcSEcCtD
Oxazepam—GABRP—uterus—ovarian cancer	0.00145	0.0337	CbGeAlD
Oxazepam—GABRR1—testis—ovarian cancer	0.00145	0.0337	CbGeAlD
Oxazepam—Lethargy—Paclitaxel—ovarian cancer	0.00143	0.0105	CcSEcCtD
Oxazepam—GABRE—uterine cervix—ovarian cancer	0.00133	0.0309	CbGeAlD
Oxazepam—Blood disorder—Epirubicin—ovarian cancer	0.00133	0.00974	CcSEcCtD
Oxazepam—Ataxia—Paclitaxel—ovarian cancer	0.00132	0.00971	CcSEcCtD
Oxazepam—GABRB1—vagina—ovarian cancer	0.00132	0.0306	CbGeAlD
Oxazepam—Leukopenia—Topotecan—ovarian cancer	0.00132	0.00967	CcSEcCtD
Oxazepam—GABRP—female reproductive system—ovarian cancer	0.0013	0.0303	CbGeAlD
Oxazepam—Leukopenia—Melphalan—ovarian cancer	0.00129	0.00947	CcSEcCtD
Oxazepam—UGT2B7—testis—ovarian cancer	0.00128	0.0298	CbGeAlD
Oxazepam—GABRE—decidua—ovarian cancer	0.00127	0.0294	CbGeAlD
Oxazepam—GABRD—testis—ovarian cancer	0.00126	0.0293	CbGeAlD
Oxazepam—Blood disorder—Doxorubicin—ovarian cancer	0.00123	0.00901	CcSEcCtD
Oxazepam—Lethargy—Docetaxel—ovarian cancer	0.00122	0.00893	CcSEcCtD
Oxazepam—GABRE—endometrium—ovarian cancer	0.0012	0.028	CbGeAlD
Oxazepam—GABRP—vagina—ovarian cancer	0.00118	0.0274	CbGeAlD
Oxazepam—Oedema—Melphalan—ovarian cancer	0.00118	0.00864	CcSEcCtD
Oxazepam—Dysarthria—Epirubicin—ovarian cancer	0.00117	0.0086	CcSEcCtD
Oxazepam—GABRA5—testis—ovarian cancer	0.00117	0.0272	CbGeAlD
Oxazepam—Vertigo—Vinorelbine—ovarian cancer	0.00113	0.0083	CcSEcCtD
Oxazepam—Leukopenia—Vinorelbine—ovarian cancer	0.00113	0.00827	CcSEcCtD
Oxazepam—Ataxia—Docetaxel—ovarian cancer	0.00112	0.00823	CcSEcCtD
Oxazepam—Gastrointestinal pain—Chlorambucil—ovarian cancer	0.0011	0.0081	CcSEcCtD
Oxazepam—Hypotension—Melphalan—ovarian cancer	0.0011	0.00807	CcSEcCtD
Oxazepam—GABRR2—lymph node—ovarian cancer	0.00109	0.0254	CbGeAlD
Oxazepam—GABRA3—testis—ovarian cancer	0.00109	0.0253	CbGeAlD
Oxazepam—Dysarthria—Doxorubicin—ovarian cancer	0.00108	0.00795	CcSEcCtD
Oxazepam—Paraesthesia—Topotecan—ovarian cancer	0.00108	0.00792	CcSEcCtD
Oxazepam—Body temperature increased—Chlorambucil—ovarian cancer	0.00107	0.00783	CcSEcCtD
Oxazepam—Abdominal pain—Chlorambucil—ovarian cancer	0.00107	0.00783	CcSEcCtD
Oxazepam—Paraesthesia—Melphalan—ovarian cancer	0.00106	0.00775	CcSEcCtD
Oxazepam—GABRE—female reproductive system—ovarian cancer	0.000996	0.0232	CbGeAlD
Oxazepam—Hypersensitivity—Chlorambucil—ovarian cancer	0.000994	0.0073	CcSEcCtD
Oxazepam—Gastrointestinal pain—Topotecan—ovarian cancer	0.000982	0.00721	CcSEcCtD
Oxazepam—Hypotension—Vinorelbine—ovarian cancer	0.00096	0.00705	CcSEcCtD
Oxazepam—Body temperature increased—Topotecan—ovarian cancer	0.000949	0.00697	CcSEcCtD
Oxazepam—Abdominal pain—Topotecan—ovarian cancer	0.000949	0.00697	CcSEcCtD
Oxazepam—GABRB3—gonad—ovarian cancer	0.000945	0.022	CbGeAlD
Oxazepam—Paraesthesia—Vinorelbine—ovarian cancer	0.000922	0.00677	CcSEcCtD
Oxazepam—Hepatic function abnormal—Epirubicin—ovarian cancer	0.000919	0.00675	CcSEcCtD
Oxazepam—GABRA2—vagina—ovarian cancer	0.000908	0.0211	CbGeAlD
Oxazepam—GABRE—female gonad—ovarian cancer	0.000906	0.0211	CbGeAlD
Oxazepam—GABRE—vagina—ovarian cancer	0.0009	0.0209	CbGeAlD
Oxazepam—Jaundice—Docetaxel—ovarian cancer	0.000895	0.00657	CcSEcCtD
Oxazepam—GABRB2—testis—ovarian cancer	0.000887	0.0206	CbGeAlD
Oxazepam—Hypersensitivity—Topotecan—ovarian cancer	0.000885	0.0065	CcSEcCtD
Oxazepam—Hypersensitivity—Melphalan—ovarian cancer	0.000866	0.00636	CcSEcCtD
Oxazepam—Agranulocytosis—Docetaxel—ovarian cancer	0.000857	0.00629	CcSEcCtD
Oxazepam—Hepatic function abnormal—Doxorubicin—ovarian cancer	0.000851	0.00625	CcSEcCtD
Oxazepam—GABRB3—female reproductive system—ovarian cancer	0.000844	0.0196	CbGeAlD
Oxazepam—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00084	0.00617	CcSEcCtD
Oxazepam—Lethargy—Epirubicin—ovarian cancer	0.00082	0.00602	CcSEcCtD
Oxazepam—Body temperature increased—Vinorelbine—ovarian cancer	0.000812	0.00596	CcSEcCtD
Oxazepam—Abdominal pain—Vinorelbine—ovarian cancer	0.000812	0.00596	CcSEcCtD
Oxazepam—Diplopia—Epirubicin—ovarian cancer	0.000804	0.0059	CcSEcCtD
Oxazepam—GABRE—testis—ovarian cancer	0.000804	0.0187	CbGeAlD
Oxazepam—Nausea—Chlorambucil—ovarian cancer	0.000801	0.00588	CcSEcCtD
Oxazepam—Vision blurred—Paclitaxel—ovarian cancer	0.000798	0.00586	CcSEcCtD
Oxazepam—Dizziness—Topotecan—ovarian cancer	0.000794	0.00583	CcSEcCtD
Oxazepam—Tremor—Paclitaxel—ovarian cancer	0.000793	0.00583	CcSEcCtD
Oxazepam—Agitation—Paclitaxel—ovarian cancer	0.000778	0.00571	CcSEcCtD
Oxazepam—CYP3A5—uterine cervix—ovarian cancer	0.000768	0.0179	CbGeAlD
Oxazepam—Vertigo—Paclitaxel—ovarian cancer	0.00076	0.00559	CcSEcCtD
Oxazepam—Syncope—Paclitaxel—ovarian cancer	0.000759	0.00558	CcSEcCtD
Oxazepam—Lethargy—Doxorubicin—ovarian cancer	0.000759	0.00557	CcSEcCtD
Oxazepam—Leukopenia—Paclitaxel—ovarian cancer	0.000758	0.00557	CcSEcCtD
Oxazepam—Rash—Topotecan—ovarian cancer	0.000757	0.00556	CcSEcCtD
Oxazepam—Hypersensitivity—Vinorelbine—ovarian cancer	0.000757	0.00556	CcSEcCtD
Oxazepam—Dermatitis—Topotecan—ovarian cancer	0.000756	0.00556	CcSEcCtD
Oxazepam—Ataxia—Epirubicin—ovarian cancer	0.000756	0.00555	CcSEcCtD
Oxazepam—Headache—Topotecan—ovarian cancer	0.000752	0.00552	CcSEcCtD
Oxazepam—Loss of consciousness—Paclitaxel—ovarian cancer	0.000744	0.00546	CcSEcCtD
Oxazepam—Diplopia—Doxorubicin—ovarian cancer	0.000743	0.00546	CcSEcCtD
Oxazepam—Rash—Melphalan—ovarian cancer	0.000741	0.00544	CcSEcCtD
Oxazepam—Dermatitis—Melphalan—ovarian cancer	0.000741	0.00544	CcSEcCtD
Oxazepam—Nausea—Topotecan—ovarian cancer	0.000713	0.00524	CcSEcCtD
Oxazepam—Ataxia—Doxorubicin—ovarian cancer	0.000699	0.00514	CcSEcCtD
Oxazepam—Nausea—Melphalan—ovarian cancer	0.000698	0.00513	CcSEcCtD
Oxazepam—Oedema—Paclitaxel—ovarian cancer	0.000691	0.00507	CcSEcCtD
Oxazepam—GABRB3—testis—ovarian cancer	0.000681	0.0158	CbGeAlD
Oxazepam—Shock—Paclitaxel—ovarian cancer	0.00068	0.00499	CcSEcCtD
Oxazepam—Dizziness—Vinorelbine—ovarian cancer	0.000679	0.00499	CcSEcCtD
Oxazepam—Rash—Vinorelbine—ovarian cancer	0.000648	0.00476	CcSEcCtD
Oxazepam—Dermatitis—Vinorelbine—ovarian cancer	0.000647	0.00475	CcSEcCtD
Oxazepam—Hypotension—Paclitaxel—ovarian cancer	0.000645	0.00474	CcSEcCtD
Oxazepam—Headache—Vinorelbine—ovarian cancer	0.000643	0.00473	CcSEcCtD
Oxazepam—Syncope—Docetaxel—ovarian cancer	0.000643	0.00473	CcSEcCtD
Oxazepam—Leukopenia—Docetaxel—ovarian cancer	0.000642	0.00472	CcSEcCtD
Oxazepam—Loss of consciousness—Docetaxel—ovarian cancer	0.000631	0.00463	CcSEcCtD
Oxazepam—Paraesthesia—Paclitaxel—ovarian cancer	0.00062	0.00456	CcSEcCtD
Oxazepam—Drowsiness—Epirubicin—ovarian cancer	0.000619	0.00455	CcSEcCtD
Oxazepam—Somnolence—Paclitaxel—ovarian cancer	0.000614	0.00451	CcSEcCtD
Oxazepam—Nausea—Vinorelbine—ovarian cancer	0.00061	0.00448	CcSEcCtD
Oxazepam—Jaundice—Epirubicin—ovarian cancer	0.000604	0.00443	CcSEcCtD
Oxazepam—GABRA2—lymph node—ovarian cancer	0.000587	0.0137	CbGeAlD
Oxazepam—Oedema—Docetaxel—ovarian cancer	0.000586	0.0043	CcSEcCtD
Oxazepam—GABRE—lymph node—ovarian cancer	0.000582	0.0135	CbGeAlD
Oxazepam—Agranulocytosis—Epirubicin—ovarian cancer	0.000578	0.00424	CcSEcCtD
Oxazepam—Shock—Docetaxel—ovarian cancer	0.000576	0.00423	CcSEcCtD
Oxazepam—Drowsiness—Doxorubicin—ovarian cancer	0.000573	0.00421	CcSEcCtD
Oxazepam—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000565	0.00415	CcSEcCtD
Oxazepam—Jaundice—Doxorubicin—ovarian cancer	0.000558	0.0041	CcSEcCtD
Oxazepam—Hypotension—Docetaxel—ovarian cancer	0.000547	0.00402	CcSEcCtD
Oxazepam—Abdominal pain—Paclitaxel—ovarian cancer	0.000546	0.00401	CcSEcCtD
Oxazepam—Body temperature increased—Paclitaxel—ovarian cancer	0.000546	0.00401	CcSEcCtD
Oxazepam—Agranulocytosis—Doxorubicin—ovarian cancer	0.000535	0.00393	CcSEcCtD
Oxazepam—Paraesthesia—Docetaxel—ovarian cancer	0.000526	0.00386	CcSEcCtD
Oxazepam—CYP3A5—female gonad—ovarian cancer	0.000524	0.0122	CbGeAlD
Oxazepam—CYP3A5—vagina—ovarian cancer	0.000521	0.0121	CbGeAlD
Oxazepam—Somnolence—Docetaxel—ovarian cancer	0.000521	0.00382	CcSEcCtD
Oxazepam—Hypersensitivity—Paclitaxel—ovarian cancer	0.000509	0.00374	CcSEcCtD
Oxazepam—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000479	0.00352	CcSEcCtD
Oxazepam—Body temperature increased—Docetaxel—ovarian cancer	0.000463	0.0034	CcSEcCtD
Oxazepam—Abdominal pain—Docetaxel—ovarian cancer	0.000463	0.0034	CcSEcCtD
Oxazepam—Dizziness—Paclitaxel—ovarian cancer	0.000457	0.00336	CcSEcCtD
Oxazepam—Vision blurred—Epirubicin—ovarian cancer	0.000456	0.00335	CcSEcCtD
Oxazepam—Agitation—Epirubicin—ovarian cancer	0.000445	0.00327	CcSEcCtD
Oxazepam—Rash—Paclitaxel—ovarian cancer	0.000436	0.0032	CcSEcCtD
Oxazepam—Dermatitis—Paclitaxel—ovarian cancer	0.000435	0.0032	CcSEcCtD
Oxazepam—Vertigo—Epirubicin—ovarian cancer	0.000435	0.00319	CcSEcCtD
Oxazepam—Syncope—Epirubicin—ovarian cancer	0.000434	0.00319	CcSEcCtD
Oxazepam—Leukopenia—Epirubicin—ovarian cancer	0.000433	0.00318	CcSEcCtD
Oxazepam—Headache—Paclitaxel—ovarian cancer	0.000433	0.00318	CcSEcCtD
Oxazepam—CYP3A4—female reproductive system—ovarian cancer	0.000432	0.01	CbGeAlD
Oxazepam—Hypersensitivity—Docetaxel—ovarian cancer	0.000431	0.00317	CcSEcCtD
Oxazepam—Loss of consciousness—Epirubicin—ovarian cancer	0.000425	0.00312	CcSEcCtD
Oxazepam—Vision blurred—Doxorubicin—ovarian cancer	0.000422	0.0031	CcSEcCtD
Oxazepam—Agitation—Doxorubicin—ovarian cancer	0.000411	0.00302	CcSEcCtD
Oxazepam—Nausea—Paclitaxel—ovarian cancer	0.00041	0.00301	CcSEcCtD
Oxazepam—Vertigo—Doxorubicin—ovarian cancer	0.000402	0.00295	CcSEcCtD
Oxazepam—Syncope—Doxorubicin—ovarian cancer	0.000402	0.00295	CcSEcCtD
Oxazepam—Leukopenia—Doxorubicin—ovarian cancer	0.000401	0.00294	CcSEcCtD
Oxazepam—Oedema—Epirubicin—ovarian cancer	0.000395	0.0029	CcSEcCtD
Oxazepam—Loss of consciousness—Doxorubicin—ovarian cancer	0.000394	0.00289	CcSEcCtD
Oxazepam—Shock—Epirubicin—ovarian cancer	0.000389	0.00285	CcSEcCtD
Oxazepam—Dizziness—Docetaxel—ovarian cancer	0.000387	0.00284	CcSEcCtD
Oxazepam—Rash—Docetaxel—ovarian cancer	0.000369	0.00271	CcSEcCtD
Oxazepam—Hypotension—Epirubicin—ovarian cancer	0.000369	0.00271	CcSEcCtD
Oxazepam—Dermatitis—Docetaxel—ovarian cancer	0.000369	0.00271	CcSEcCtD
Oxazepam—Headache—Docetaxel—ovarian cancer	0.000367	0.00269	CcSEcCtD
Oxazepam—Oedema—Doxorubicin—ovarian cancer	0.000365	0.00268	CcSEcCtD
Oxazepam—Shock—Doxorubicin—ovarian cancer	0.00036	0.00264	CcSEcCtD
Oxazepam—Paraesthesia—Epirubicin—ovarian cancer	0.000355	0.0026	CcSEcCtD
Oxazepam—Somnolence—Epirubicin—ovarian cancer	0.000351	0.00258	CcSEcCtD
Oxazepam—Nausea—Docetaxel—ovarian cancer	0.000348	0.00255	CcSEcCtD
Oxazepam—Hypotension—Doxorubicin—ovarian cancer	0.000341	0.00251	CcSEcCtD
Oxazepam—Paraesthesia—Doxorubicin—ovarian cancer	0.000328	0.00241	CcSEcCtD
Oxazepam—Somnolence—Doxorubicin—ovarian cancer	0.000325	0.00239	CcSEcCtD
Oxazepam—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000323	0.00237	CcSEcCtD
Oxazepam—Abdominal pain—Epirubicin—ovarian cancer	0.000312	0.00229	CcSEcCtD
Oxazepam—Body temperature increased—Epirubicin—ovarian cancer	0.000312	0.00229	CcSEcCtD
Oxazepam—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000299	0.00219	CcSEcCtD
Oxazepam—Hypersensitivity—Epirubicin—ovarian cancer	0.000291	0.00214	CcSEcCtD
Oxazepam—Body temperature increased—Doxorubicin—ovarian cancer	0.000289	0.00212	CcSEcCtD
Oxazepam—Abdominal pain—Doxorubicin—ovarian cancer	0.000289	0.00212	CcSEcCtD
Oxazepam—Hypersensitivity—Doxorubicin—ovarian cancer	0.000269	0.00198	CcSEcCtD
Oxazepam—Dizziness—Epirubicin—ovarian cancer	0.000261	0.00192	CcSEcCtD
Oxazepam—Rash—Epirubicin—ovarian cancer	0.000249	0.00183	CcSEcCtD
Oxazepam—Dermatitis—Epirubicin—ovarian cancer	0.000249	0.00183	CcSEcCtD
Oxazepam—Headache—Epirubicin—ovarian cancer	0.000247	0.00182	CcSEcCtD
Oxazepam—Dizziness—Doxorubicin—ovarian cancer	0.000242	0.00177	CcSEcCtD
Oxazepam—Nausea—Epirubicin—ovarian cancer	0.000235	0.00172	CcSEcCtD
Oxazepam—Rash—Doxorubicin—ovarian cancer	0.00023	0.00169	CcSEcCtD
Oxazepam—Dermatitis—Doxorubicin—ovarian cancer	0.00023	0.00169	CcSEcCtD
Oxazepam—Headache—Doxorubicin—ovarian cancer	0.000229	0.00168	CcSEcCtD
Oxazepam—Nausea—Doxorubicin—ovarian cancer	0.000217	0.00159	CcSEcCtD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.78e-05	0.00109	CbGpPWpGaD
Oxazepam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.77e-05	0.00109	CbGpPWpGaD
Oxazepam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	7.77e-05	0.00109	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SLC5A5—ovarian cancer	7.77e-05	0.00109	CbGpPWpGaD
Oxazepam—GABRR2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.72e-05	0.00109	CbGpPWpGaD
Oxazepam—GABRQ—Transmembrane transport of small molecules—ABCB1—ovarian cancer	7.72e-05	0.00109	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—CTNNB1—ovarian cancer	7.71e-05	0.00108	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.68e-05	0.00108	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.63e-05	0.00107	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYTB—ovarian cancer	7.53e-05	0.00106	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.51e-05	0.00106	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—SLC2A1—ovarian cancer	7.5e-05	0.00105	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—YAP1—ovarian cancer	7.49e-05	0.00105	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	7.43e-05	0.00104	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	7.41e-05	0.00104	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	7.33e-05	0.00103	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.28e-05	0.00102	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—MAPK1—ovarian cancer	7.28e-05	0.00102	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CYP1B1—ovarian cancer	7.19e-05	0.00101	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	7.02e-05	0.000987	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.82e-05	0.000959	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.78e-05	0.000954	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	6.73e-05	0.000946	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—STAT3—ovarian cancer	6.72e-05	0.000945	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.71e-05	0.000943	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.7e-05	0.000942	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.59e-05	0.000926	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.58e-05	0.000926	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—BRIP1—ovarian cancer	6.58e-05	0.000925	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PPP1CC—ovarian cancer	6.58e-05	0.000925	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.56e-05	0.000923	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.54e-05	0.00092	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.52e-05	0.000916	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.47e-05	0.00091	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	6.44e-05	0.000906	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	6.42e-05	0.000903	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—MAPK3—ovarian cancer	6.42e-05	0.000903	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.4e-05	0.0009	CbGpPWpGaD
Oxazepam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	6.4e-05	0.0009	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PPP2R1A—ovarian cancer	6.38e-05	0.000897	CbGpPWpGaD
Oxazepam—GABRG3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.36e-05	0.000894	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.36e-05	0.000894	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.32e-05	0.000888	CbGpPWpGaD
Oxazepam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	6.3e-05	0.000886	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.29e-05	0.000884	CbGpPWpGaD
Oxazepam—GABRB1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	6.27e-05	0.000881	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.25e-05	0.000879	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	6.21e-05	0.000873	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	6.2e-05	0.000872	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	6.14e-05	0.000863	CbGpPWpGaD
Oxazepam—GABRR1—Transmission across Chemical Synapses—HRAS—ovarian cancer	6.12e-05	0.000861	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYTB—ovarian cancer	6.11e-05	0.00086	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—MAPK1—ovarian cancer	6.11e-05	0.000859	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—FASN—ovarian cancer	6.1e-05	0.000858	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SLC5A5—ovarian cancer	6e-05	0.000844	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.99e-05	0.000843	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	5.98e-05	0.00084	CbGpPWpGaD
Oxazepam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.96e-05	0.000839	CbGpPWpGaD
Oxazepam—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.93e-05	0.000834	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—ABCB1—ovarian cancer	5.92e-05	0.000833	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.9e-05	0.00083	CbGpPWpGaD
Oxazepam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.89e-05	0.000828	CbGpPWpGaD
Oxazepam—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.85e-05	0.000823	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—MAPK1—ovarian cancer	5.84e-05	0.000822	CbGpPWpGaD
Oxazepam—GABRR2—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.84e-05	0.000821	CbGpPWpGaD
Oxazepam—GABRQ—Transmission across Chemical Synapses—HRAS—ovarian cancer	5.84e-05	0.000821	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—TYMS—ovarian cancer	5.82e-05	0.000818	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—SLC2A1—ovarian cancer	5.8e-05	0.000815	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—NME2—ovarian cancer	5.77e-05	0.000811	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	5.61e-05	0.000789	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.58e-05	0.000785	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—MAPK1—ovarian cancer	5.57e-05	0.000784	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—MAPK1—ovarian cancer	5.57e-05	0.000784	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CYP1B1—ovarian cancer	5.56e-05	0.000782	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.51e-05	0.000775	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	5.46e-05	0.000768	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	5.42e-05	0.000762	CbGpPWpGaD
Oxazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.39e-05	0.000757	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	5.36e-05	0.000754	CbGpPWpGaD
Oxazepam—GABRB2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.35e-05	0.000753	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—BRIP1—ovarian cancer	5.34e-05	0.000752	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PPP1CC—ovarian cancer	5.34e-05	0.000752	CbGpPWpGaD
Oxazepam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.23e-05	0.000736	CbGpPWpGaD
Oxazepam—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.2e-05	0.000731	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYTB—ovarian cancer	5.14e-05	0.000723	CbGpPWpGaD
Oxazepam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.14e-05	0.000723	CbGpPWpGaD
Oxazepam—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.11e-05	0.000718	CbGpPWpGaD
Oxazepam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.05e-05	0.00071	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	5.04e-05	0.000709	CbGpPWpGaD
Oxazepam—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	5.02e-05	0.000706	CbGpPWpGaD
Oxazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	5.02e-05	0.000705	CbGpPWpGaD
Oxazepam—GABRB3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.99e-05	0.000701	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PPP2R1A—ovarian cancer	4.93e-05	0.000693	CbGpPWpGaD
Oxazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.93e-05	0.000693	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—HRAS—ovarian cancer	4.9e-05	0.00069	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.9e-05	0.000689	CbGpPWpGaD
Oxazepam—GABRG2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.9e-05	0.000689	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.81e-05	0.000677	CbGpPWpGaD
Oxazepam—GABRG3—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.81e-05	0.000676	CbGpPWpGaD
Oxazepam—GABRB1—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.74e-05	0.000666	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.73e-05	0.000665	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.7e-05	0.000661	CbGpPWpGaD
Oxazepam—GABRR1—Neuronal System—HRAS—ovarian cancer	4.69e-05	0.00066	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—CAV1—ovarian cancer	4.69e-05	0.000659	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.61e-05	0.000649	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—MAPK1—ovarian cancer	4.59e-05	0.000646	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—ABCB1—ovarian cancer	4.58e-05	0.000644	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—MAPK1—ovarian cancer	4.52e-05	0.000636	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—BRIP1—ovarian cancer	4.5e-05	0.000632	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PPP1CC—ovarian cancer	4.5e-05	0.000632	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—TYMS—ovarian cancer	4.49e-05	0.000632	CbGpPWpGaD
Oxazepam—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.48e-05	0.00063	CbGpPWpGaD
Oxazepam—GABRQ—Neuronal System—HRAS—ovarian cancer	4.48e-05	0.000629	CbGpPWpGaD
Oxazepam—GABRR2—Neuronal System—HRAS—ovarian cancer	4.48e-05	0.000629	CbGpPWpGaD
Oxazepam—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.43e-05	0.000623	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—YAP1—ovarian cancer	4.41e-05	0.00062	CbGpPWpGaD
Oxazepam—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	4.4e-05	0.000619	CbGpPWpGaD
Oxazepam—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	4.34e-05	0.00061	CbGpPWpGaD
Oxazepam—GABRB3—BDNF signaling pathway—AKT1—ovarian cancer	4.33e-05	0.000609	CbGpPWpGaD
Oxazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	4.31e-05	0.000605	CbGpPWpGaD
Oxazepam—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	4.28e-05	0.000602	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—MAPK1—ovarian cancer	4.28e-05	0.000602	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PIK3CG—ovarian cancer	4.27e-05	0.0006	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—MAPK1—ovarian cancer	4.22e-05	0.000594	CbGpPWpGaD
Oxazepam—GABRB2—Transmission across Chemical Synapses—HRAS—ovarian cancer	4.05e-05	0.000569	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	4.03e-05	0.000567	CbGpPWpGaD
Oxazepam—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.93e-05	0.000553	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	3.89e-05	0.000548	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—MAPK1—ovarian cancer	3.86e-05	0.000543	CbGpPWpGaD
Oxazepam—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.86e-05	0.000543	CbGpPWpGaD
Oxazepam—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.8e-05	0.000534	CbGpPWpGaD
Oxazepam—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	3.78e-05	0.000531	CbGpPWpGaD
Oxazepam—GABRB3—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.77e-05	0.00053	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—MAPK1—ovarian cancer	3.75e-05	0.000528	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PIK3CD—ovarian cancer	3.75e-05	0.000528	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYTB—ovarian cancer	3.72e-05	0.000523	CbGpPWpGaD
Oxazepam—GABRG2—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.7e-05	0.000521	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—MAPK1—ovarian cancer	3.69e-05	0.000518	CbGpPWpGaD
Oxazepam—GABRG3—Neuronal System—HRAS—ovarian cancer	3.69e-05	0.000518	CbGpPWpGaD
Oxazepam—GABRB1—Neuronal System—HRAS—ovarian cancer	3.63e-05	0.000511	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—MAPK1—ovarian cancer	3.62e-05	0.000509	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—CAV1—ovarian cancer	3.62e-05	0.000509	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—MAPK1—ovarian cancer	3.6e-05	0.000506	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—FASN—ovarian cancer	3.6e-05	0.000506	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—YAP1—ovarian cancer	3.58e-05	0.000504	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.55e-05	0.000499	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SLC5A5—ovarian cancer	3.54e-05	0.000497	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—MAPK1—ovarian cancer	3.53e-05	0.000497	CbGpPWpGaD
Oxazepam—GABRA6—Neuronal System—HRAS—ovarian cancer	3.44e-05	0.000483	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—SLC2A1—ovarian cancer	3.42e-05	0.00048	CbGpPWpGaD
Oxazepam—GABRA4—Neuronal System—HRAS—ovarian cancer	3.39e-05	0.000477	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PIK3CG—ovarian cancer	3.3e-05	0.000464	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CYP1B1—ovarian cancer	3.28e-05	0.000461	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PIK3CB—ovarian cancer	3.27e-05	0.00046	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—BRIP1—ovarian cancer	3.25e-05	0.000457	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PPP1CC—ovarian cancer	3.25e-05	0.000457	CbGpPWpGaD
Oxazepam—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	3.24e-05	0.000455	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.12e-05	0.000439	CbGpPWpGaD
Oxazepam—GABRB2—Neuronal System—HRAS—ovarian cancer	3.1e-05	0.000436	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—MAPK1—ovarian cancer	3.09e-05	0.000434	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—YAP1—ovarian cancer	3.01e-05	0.000424	CbGpPWpGaD
Oxazepam—GABRA5—Neuronal System—HRAS—ovarian cancer	3.01e-05	0.000424	CbGpPWpGaD
Oxazepam—GABRA3—Neuronal System—HRAS—ovarian cancer	2.96e-05	0.000416	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—FASN—ovarian cancer	2.92e-05	0.000411	CbGpPWpGaD
Oxazepam—GABRA2—Neuronal System—HRAS—ovarian cancer	2.91e-05	0.000409	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PPP2R1A—ovarian cancer	2.9e-05	0.000409	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PIK3CD—ovarian cancer	2.9e-05	0.000408	CbGpPWpGaD
Oxazepam—GABRB3—Neuronal System—HRAS—ovarian cancer	2.89e-05	0.000406	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SLC5A5—ovarian cancer	2.87e-05	0.000404	CbGpPWpGaD
Oxazepam—GABRG2—Neuronal System—HRAS—ovarian cancer	2.84e-05	0.000399	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PTEN—ovarian cancer	2.83e-05	0.000397	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—SLC2A1—ovarian cancer	2.78e-05	0.00039	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.72e-05	0.000382	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—ABCB1—ovarian cancer	2.7e-05	0.000379	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—NME2—ovarian cancer	2.68e-05	0.000377	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CYP1B1—ovarian cancer	2.66e-05	0.000374	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—TYMS—ovarian cancer	2.65e-05	0.000373	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PIK3CB—ovarian cancer	2.53e-05	0.000355	CbGpPWpGaD
Oxazepam—GABRA1—Neuronal System—HRAS—ovarian cancer	2.48e-05	0.000349	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—FASN—ovarian cancer	2.46e-05	0.000346	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SLC5A5—ovarian cancer	2.42e-05	0.00034	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PPP2R1A—ovarian cancer	2.36e-05	0.000332	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.35e-05	0.00033	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—SLC2A1—ovarian cancer	2.33e-05	0.000328	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CYP1B1—ovarian cancer	2.24e-05	0.000315	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—ABCB1—ovarian cancer	2.19e-05	0.000308	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PTEN—ovarian cancer	2.18e-05	0.000307	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—YAP1—ovarian cancer	2.18e-05	0.000306	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—TYMS—ovarian cancer	2.15e-05	0.000303	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—CAV1—ovarian cancer	2.13e-05	0.0003	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—PIK3CA—ovarian cancer	1.99e-05	0.00028	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PPP2R1A—ovarian cancer	1.99e-05	0.000279	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PIK3CG—ovarian cancer	1.94e-05	0.000273	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—ABCB1—ovarian cancer	1.84e-05	0.000259	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—TYMS—ovarian cancer	1.81e-05	0.000255	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—FASN—ovarian cancer	1.78e-05	0.00025	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SLC5A5—ovarian cancer	1.75e-05	0.000246	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—CAV1—ovarian cancer	1.73e-05	0.000244	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYTB—ovarian cancer	1.73e-05	0.000243	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PIK3CD—ovarian cancer	1.71e-05	0.00024	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—SLC2A1—ovarian cancer	1.69e-05	0.000237	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.66e-05	0.000233	CbGpPWpGaD
Oxazepam—UGT2B15—Metabolism—AKT1—ovarian cancer	1.63e-05	0.000229	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CYP1B1—ovarian cancer	1.62e-05	0.000228	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PIK3CG—ovarian cancer	1.58e-05	0.000222	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—PIK3CA—ovarian cancer	1.54e-05	0.000217	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.51e-05	0.000212	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.51e-05	0.000212	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PIK3CB—ovarian cancer	1.49e-05	0.00021	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—CAV1—ovarian cancer	1.46e-05	0.000205	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PPP2R1A—ovarian cancer	1.44e-05	0.000202	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PIK3CD—ovarian cancer	1.39e-05	0.000195	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—ABCB1—ovarian cancer	1.33e-05	0.000187	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PIK3CG—ovarian cancer	1.33e-05	0.000187	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—TYMS—ovarian cancer	1.31e-05	0.000184	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PTEN—ovarian cancer	1.29e-05	0.000181	CbGpPWpGaD
Oxazepam—CYP3A43—Metabolism—AKT1—ovarian cancer	1.26e-05	0.000177	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PIK3CB—ovarian cancer	1.21e-05	0.00017	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PIK3CD—ovarian cancer	1.17e-05	0.000164	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—CAV1—ovarian cancer	1.05e-05	0.000148	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PTEN—ovarian cancer	1.05e-05	0.000147	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PIK3CB—ovarian cancer	1.02e-05	0.000143	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—YAP1—ovarian cancer	1.01e-05	0.000142	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PIK3CG—ovarian cancer	9.61e-06	0.000135	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—PIK3CA—ovarian cancer	9.08e-06	0.000128	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PTEN—ovarian cancer	8.8e-06	0.000124	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PIK3CD—ovarian cancer	8.44e-06	0.000119	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—FASN—ovarian cancer	8.26e-06	0.000116	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SLC5A5—ovarian cancer	8.12e-06	0.000114	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—SLC2A1—ovarian cancer	7.85e-06	0.00011	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CYP1B1—ovarian cancer	7.52e-06	0.000106	CbGpPWpGaD
Oxazepam—UGT2B7—Metabolism—AKT1—ovarian cancer	7.42e-06	0.000104	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—PIK3CA—ovarian cancer	7.38e-06	0.000104	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PIK3CB—ovarian cancer	7.36e-06	0.000104	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	6.67e-06	9.38e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PTEN—ovarian cancer	6.36e-06	8.94e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—PIK3CA—ovarian cancer	6.21e-06	8.73e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—ABCB1—ovarian cancer	6.19e-06	8.71e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—TYMS—ovarian cancer	6.08e-06	8.56e-05	CbGpPWpGaD
Oxazepam—UGT1A9—Metabolism—AKT1—ovarian cancer	6.03e-06	8.48e-05	CbGpPWpGaD
Oxazepam—CYP3A7—Metabolism—AKT1—ovarian cancer	5.07e-06	7.13e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—CAV1—ovarian cancer	4.9e-06	6.89e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—PIK3CA—ovarian cancer	4.49e-06	6.31e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PIK3CG—ovarian cancer	4.47e-06	6.28e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PIK3CD—ovarian cancer	3.93e-06	5.52e-05	CbGpPWpGaD
Oxazepam—CYP3A5—Metabolism—AKT1—ovarian cancer	3.67e-06	5.15e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PIK3CB—ovarian cancer	3.42e-06	4.81e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PTEN—ovarian cancer	2.96e-06	4.16e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—PIK3CA—ovarian cancer	2.09e-06	2.93e-05	CbGpPWpGaD
Oxazepam—CYP3A4—Metabolism—AKT1—ovarian cancer	1.7e-06	2.4e-05	CbGpPWpGaD
